These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
433 related articles for article (PubMed ID: 18186553)
41. Cardiovascular Risk Reduction in Patients with Nonalcoholic Fatty Liver Disease: The Potential Role of Ezetimibe. Simon TG; Corey KE; Chung RT; Giugliano R Dig Dis Sci; 2016 Dec; 61(12):3425-3435. PubMed ID: 27714510 [TBL] [Abstract][Full Text] [Related]
42. Role of fatty acids in the pathogenesis of obesity and fatty liver: impact of bariatric surgery. Verna EC; Berk PD Semin Liver Dis; 2008 Nov; 28(4):407-26. PubMed ID: 18956297 [TBL] [Abstract][Full Text] [Related]
43. Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults. Vernon G; Baranova A; Younossi ZM Aliment Pharmacol Ther; 2011 Aug; 34(3):274-85. PubMed ID: 21623852 [TBL] [Abstract][Full Text] [Related]
44. Systematic review: association of polycystic ovary syndrome with metabolic syndrome and non-alcoholic fatty liver disease. Baranova A; Tran TP; Birerdinc A; Younossi ZM Aliment Pharmacol Ther; 2011 Apr; 33(7):801-14. PubMed ID: 21251033 [TBL] [Abstract][Full Text] [Related]
45. Characteristics and diagnosis of NAFLD/NASH. Hashimoto E; Taniai M; Tokushige K J Gastroenterol Hepatol; 2013 Dec; 28 Suppl 4():64-70. PubMed ID: 24251707 [TBL] [Abstract][Full Text] [Related]
46. From the metabolic syndrome to NAFLD or vice versa? Vanni E; Bugianesi E; Kotronen A; De Minicis S; Yki-Järvinen H; Svegliati-Baroni G Dig Liver Dis; 2010 May; 42(5):320-30. PubMed ID: 20207596 [TBL] [Abstract][Full Text] [Related]
54. ASH and NASH. Scaglioni F; Ciccia S; Marino M; Bedogni G; Bellentani S Dig Dis; 2011; 29(2):202-10. PubMed ID: 21734385 [TBL] [Abstract][Full Text] [Related]
55. Metabolic syndrome and nonalcoholic fatty liver disease: Is insulin resistance the link? Asrih M; Jornayvaz FR Mol Cell Endocrinol; 2015 Dec; 418 Pt 1():55-65. PubMed ID: 25724480 [TBL] [Abstract][Full Text] [Related]
56. Comparative review of diets for the metabolic syndrome: implications for nonalcoholic fatty liver disease. Zivkovic AM; German JB; Sanyal AJ Am J Clin Nutr; 2007 Aug; 86(2):285-300. PubMed ID: 17684197 [TBL] [Abstract][Full Text] [Related]
57. Association between the CYBA and NOX4 genes of NADPH oxidase and its relationship with metabolic syndrome in non-alcoholic fatty liver disease in Brazilian population. Rabelo F; Stefano JT; Cavaleiro AM; Lima RVC; de Campos Mazo DF; Carrilho FJ; Correa-Giannella ML; Oliveira CP Hepatobiliary Pancreat Dis Int; 2018 Aug; 17(4):330-335. PubMed ID: 30087027 [TBL] [Abstract][Full Text] [Related]